— Know what they know.
Not Investment Advice
Also trades as: 0I0J.L (LSE) · $vol 0M

CLX NYSE

The Clorox Company
1W: -0.1% 1M: +7.3% 3M: -11.3% YTD: -10.3% 1Y: -21.9% 3Y: -20.2% 5Y: -34.5%
$87.36
+0.60 (+0.69%)
After Hours: $87.34 (-0.02, -0.02%)
Weekly Expected Move ±4.3%
$79 $83 $86 $90 $94
NYSE · Consumer Defensive · Household & Personal Products · Tech Score Buy · Power 61 · $10.6B mcap · 120M float · 2.27% daily turnover · Short 59% of daily vol
Credit Risk of going bust: lower than 58% of companies Debt: 34.5% of company value Bonds: $83.6M held by 175 funds, 62 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.05 (down 97%), The Clorox Company would be worth roughly what it owes.
Total debt $5.52B against a stock market value of $10.49B.
Distance to default 5.93 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.08B (short-term plus half of long-term), stock volatility 32.1%; Altman Z 2.01. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$7.8B +40.2% ▲
5Y CAGR: +4.2%
Total Liabilities
$7.5B +48.5% ▲
5Y CAGR: +5.6%
Shareholders Equity
$90M -72.0% ▼
5Y CAGR: -26.2%
Cash & Investments
$143M -14.4% ▼
5Y CAGR: -14.8%
Total Debt
$5.5B +91.7% ▲
5Y CAGR: +11.8%
Net Debt
$5.4B +98.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$183M$367M$202M$167M$143M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$183M$367M$202M$167M$143M
Net Receivables$681M$688M$695M$821M$791M
Inventory$755M$696M$637M$523M$777M
Other Current Assets$0$77M$88M$97M$113M
Total Current Assets$1.7B$1.8B$1.6B$1.6B$1.8B
Property, Plant & Equip.$1.7B$1.7B$1.7B$1.6B$1.9B
Goodwill & Intangibles$2.4B$2.0B$1.9B$1.8B$2.6B
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$315M$462M$545M$558M$1.5B
Total Non-Current Assets$4.4B$4.1B$4.1B$4.0B$6.0B
Total Assets$6.2B$5.9B$5.8B$5.6B$7.8B
— Liabilities —
Accounts Payable$960M$1.0B$950M$838M$1.6B
Short-Term Debt$237M$50M$4M$4M$1.1B
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$176M$262M$190M$179M$0
Total Current Liabilities$1.8B$1.9B$1.6B$1.9B$2.8B
Long-Term Debt$2.5B$2.5B$2.5B$2.5B$4.0B
Other Non-Current Liab.$791M$825M$848M$351M$405M
Total Non-Current Liabilities$3.6B$3.6B$3.7B$3.2B$4.8B
Total Liabilities$5.4B$5.6B$5.3B$5.1B$7.5B
— Equity —
Common Stock$131M$131M$131M$131M$131M
Retained Earnings$1.0B$583M$250M$432M$386M
Accumulated OCI-$479M-$493M-$155M-$157M-$157M
Total Stockholders Equity$556M$220M$328M$321M$90M
Total Liabilities & Equity$6.2B$5.9B$5.8B$5.6B$7.8B
— Key Metrics —
Total Debt$3.1B$2.9B$2.9B$2.9B$5.5B
Net Debt$2.9B$2.6B$2.7B$2.7B$5.4B
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms